title: Bortezomib for antibody-mediated rejection in a young lung transplant recipient.
authors.affiliation: Department of Pediatrics, The Ohio State University, Columbus, OH, USA. hayes.705@osu.edu.|Department of Internal Medicine, The Ohio State University, Columbus, OH, USA. hayes.705@osu.edu.|Section of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, OH, USA. hayes.705@osu.edu.
authors.forename: Don
authors.initials: D
authors.lastname: Hayes
authors.affiliation: Section of Pulmonary Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
authors.forename: Kerri L
authors.initials: KL
authors.lastname: Nicholson
authors.affiliation: Department of Pathology, The Ohio State University, Columbus, OH, USA.|Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, OH, USA.
authors.forename: Peter B
authors.initials: PB
authors.lastname: Baker
mesh_terms: D000906:Antibodies / Q000276:immunology*; D000069286:Bortezomib / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007223:Infant; D008168:Lung / Q000473:pathology; D008171:Lung Diseases / Q000601:surgery*; D016040:Lung Transplantation / Q000009:adverse effects*; D000069283:Rituximab / Q000008:administration & dosage; D066027:Transplant Recipients
chemical_list: D000906:Antibodies; D016756:Immunoglobulins, Intravenous; D000069283:Rituximab; D000069286:Bortezomib